Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Shah, N.
space
  arrow  Concato, J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Effects of Dietary Protein on Renal Disease

right arrow Nirav Shah, AB; Ralph I. Horwitz, MD; and John Concato, MD, MS, MPH

15 February 1997 | Volume 126 Issue 4 | Page 331


TO THE EDITOR:

The recent meta-analysis of low-protein diets in diabetic and nondiabetic renal disease by Pedrini and colleagues [1] contains examples of three limitations of meta-analysis in clinical medicine. First, the criteria used for study selection were inconsistent. For nondiabetic nephropathy, the meta-analysis included only randomized trials that had end points of end-stage renal disease or death. The meta-analysis of diabetic nephropathy, however, included two observational studies, and only one of three randomized trials used intention-to-treat analysis. In addition, the studies of diabetic nephropathy used surrogate outcomes of glomerular filtration rate, urinary albumin excretion rate, and creatinine clearance. Thus, the studies of nondiabetic nephropathy were held to a higher standard than were the studies of diabetic nephropathy.

Second, the lack of attention to clinical distinctions of patients in different studies threatens the clinical relevance of the results. Among studies of nondiabetic nephropathy, the mean serum creatinine level ranged from 1.9 to 7.4 mg/dL; among studies of diabetic nephropathy, urinary protein excretion ranged from 48 to 5700 mg/d. Although the point estimates for the effectiveness of low-protein diets may be mathematically correct, these average results among patients with disparate severities of illness may not be accurate for individual patients.

Third, the statistical focus of a meta-analysis can be a problem rather than a virtue. In the meta-analysis of 1413 patients with nondiabetic nephropathy, the overall P value was 0.007. In the meta-analysis of 108 patients with diabetic nephropathy (which used only surrogate outcomes), the corresponding P value was 0.00036. Despite the enhanced statistical significance of the second meta-analysis, the authors state that "these studies included fewer patients and used more varied study designs and surrogate end points. In our view, these results are not as strong a justification for the use of dietary restriction protein [sic] in routine clinical practice." Thus, when interpreting results, the authors resort to their best judgment-a time-honored practice that is, in our view, desirable but that meta-analysis was intended to replace.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowREFERENCE

Yale University School of Medicine, West Haven Veterans Affairs Medical Center, New Haven, CT 06520-8025


REFERENCE
space
up arrowTop
up arrowAuthor & Article Info
dotREFERENCE

1. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med. 1996; 124:627-32.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Shah, N.
space
  arrow  Concato, J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online